We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
-5.27%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$182M
AUM Growth
-$18.6M
Cap. Flow
+$4.63M
Cap. Flow %
2.55%
Top 10 Hldgs %
89.05%
Holding
42
New
2
Increased
2
Reduced
2
Closed
4

Top Buys

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$5.09M
2
ALDX icon
Aldeyra Therapeutics
ALDX
+$1.45M
3
OSK icon
Oshkosh
OSK
+$923K
4
AG icon
First Majestic Silver
AG
+$398K

Top Sells

Rank Stock Value
1
VMW
VMware, Inc
VMW
+$1.03M
2
XCUR icon
Exicure
XCUR
+$962K
3
ABEO icon
Abeona Therapeutics
ABEO
+$473K
4
SNGX icon
Soligenix
SNGX
+$316K
5
SVM
Silvercorp Metals
SVM
+$267K

Sector Composition

Rank Sector Weight
1 Healthcare 85.51%
2 Technology 3.12%
3 Materials 2.61%
4 Financials 2.28%
5 Industrials 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTAI icon
26
BioXcel Therapeutics
BTAI
$27.8M
$407K 0.22%
1,250
– –
PAAS icon
27
Pan American Silver
PAAS
$21.6B
$407K 0.22%
8,200
– –
SILV
28
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$381K 0.21%
42,000
– –
AG icon
29
First Majestic Silver
AG
$9.07B
$376K 0.21%
+33,000
New +$398K
AEM icon
30
Agnico Eagle Mines
AEM
$90.5B
$367K 0.2%
6,900
– –
MAG
31
DELISTED
MAG Silver
MAG
$341K 0.19%
17,300
– –
EQX icon
32
Equinox Gold
EQX
$13.5B
$308K 0.17%
45,500
– –
SNGX icon
33
Soligenix
SNGX
$5.81M
$288K 0.16%
1,821
-1,465
-45% -$316K
ANVS icon
34
Annovis Bio
ANVS
$80M
$250K 0.14%
14,210
– –
AGTC
35
DELISTED
Applied Genetic Technologies Corporation
AGTC
$190K 0.1%
100,000
– –
ELTX icon
36
Elicio Therapeutics
ELTX
$83.8M
$174K 0.1%
6,000
– –
FSM icon
37
Fortuna Silver Mines
FSM
$3.07B
– –
-43,700
Closed -$172K
SVM
38
Silvercorp Metals
SVM
$2.53B
– –
-70,000
Closed -$267K
XCUR icon
39
Exicure
XCUR
$8.57M
– –
-5,346
Closed -$962K
VMW
40
DELISTED
VMware, Inc
VMW
– –
-6,950
Closed -$1.03M
1
2

Similar funds

FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return
V
ViaWealth Leawood, Kansas $180M AUM 20.16% 1-Year Est. Return
RVM
Robinson Value Management San Antonio, Texas $180M AUM 24.17% 1-Year Est. Return

Knoll Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Knoll Capital Management held 42 positions worth $182M, down 9.3% from $201M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Knoll Capital Management's Q4 2021 filing shows 2 new, 2 increased, 2 reduced and 4 closed positions. Its largest new stake was Oshkosh: 8,450 shares worth $925K. The largest sale was VMware, Inc, an estimated $1.03M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 87% a quarter earlier, followed by Technology and Materials.

  • Knoll Capital Management's largest Q4 2021 buy was Oshkosh: 8,450 shares worth $925K.
  • Knoll Capital Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q4 2021, an estimated $5.09M increase.
  • Knoll Capital Management's biggest Q4 2021 reduction was Abeona Therapeutics, cutting an estimated $473K.
  • Knoll Capital Management fully exited VMware, Inc in Q4 2021, selling an estimated $1.03M.
  • Knoll Capital Management's ten largest holdings make up 89% of its $182M portfolio in Q4 2021.
  • Knoll Capital Management opened 2 new positions and closed 4 in Q4 2021.
  • Knoll Capital Management's portfolio value fell 9.3% quarter-over-quarter to $182M.

Based on Knoll Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.